AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 273: F104-F112, 1997;
0363-6127/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dukacz, S. A.
Right arrow Articles by Kline, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dukacz, S. A.
Right arrow Articles by Kline, R. L.

AJP - Renal Physiology, Vol 273, Issue 1 104-F112, Copyright © 1997 by American Physiological Society


ARTICLES

The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats

S. A. Dukacz, M. A. Adams and R. L. Kline
Department of Physiology, University of Western Ontario, London, Canada.

Long-term angiotensin-converting enzyme inhibitor treatment has been shown to have a persistent antihypertensive effect in spontaneously hypertensive rats (SHR) long after discontinuation of treatment. To test the hypothesis that this persistent effect involves a shift in the pressure-natriuresis relation, we performed experiments in male, anesthetized SHR at 18 wk of age with fixed neural and hormonal influences on the kidney. Renal function was assessed at various levels of arterial pressure using standard clearance techniques. Enalapril (25 mg.kg-1.day-1 in drinking water) was administered from 4 to 14 wk of age and again 3 days before renal function studies. The following four groups of SHR were studied: 1) 10-wk treatment, 2) 10-wk + 3-day treatment, 3) 3-day treatment, and 4) untreated. Groups 1 and 4 had an intact renin-angiotensin system; groups 2 and 3 had the renin-angiotensin system blocked. Mean arterial pressure (MAP, mmHg; means +/- SE) under Inactin anesthesia was 139 +/- 4 (n = 9), 109 +/- 3 (n = 8), 149 +/- 1 (n = 9), and 181 +/- 7 mmHg (n = 9) for each of the four groups, respectively. Glomerular filtration rate was similar in all groups at resting levels of MAP, whereas renal blood flow was elevated in all treatment groups when compared with that in untreated SHR. Pressure-natriuresis, pressure-diuresis, and pressure-fractional sodium excretion curves for the 10-wk treatment group and 3-day only treatment group were shifted leftward to significantly lower pressures by approximately 25 mmHg, compared with the untreated group. The curves for the treated +3-day group were shifted an additional 30 mmHg to the left. The relationship between renal artery pressure (RAP) and renal interstitial hydrostatic pressure was also shifted 25-30 mmHg but only in rats that received the long-term treatment with enalapril. Three-day enalapril had no significant effect on this relationship. These data indicate that the persistent effect of long-term enalapril treatment on arterial pressure in SHR is the result of a shift in the pressure-natriuresis relationship. The mechanism for this effect involves hemodynamic changes that act to improve transmission of RAP to the interstitium, resulting in enhanced sodium excretion for a given level of RAP.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
L. E. Yang, P. K. K. Leong, and A. A. McDonough
Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1197 - F1208.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Bertram, N. Blanc-Brunat, J. Sassard, and M. Lo
Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1041 - R1045.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M.-G. Feng, S. A. W. Dukacz, and R. L. Kline
Selective effect of tempol on renal medullary hemodynamics in spontaneously hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1420 - R1425.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. W. Dukacz, M.-G. Feng, L.-F. Yang, R. M. K. W. Lee, and R. L. Kline
Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1076 - R1084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Ito, K. Omata, S. Ito, K. M. Hoagland, and R. J. Roman
Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R822 - R830.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. MERVAALA, B. DEHMEL, V. GROSS, A. LIPPOLDT, J. BOHLENDER, A. F. MILIA, D. GANTEN, and F. C. LUFT
Angiotensin-Converting Enzyme Inhibition and AT1 Receptor Blockade Modify the Pressure-Natriuresis Relationship by Additive Mechanisms in Rats with Human Renin and Angiotensinogen Genes
J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1669 - 1680.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. W. Dukacz, M. A. Adams, and R. L. Kline
Short- and long-term enalapril affect renal medullary hemodynamics in the spontaneously hypertensive rat
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R10 - R16.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online